M, H. (2025). Comparison of inflammatory control and safety by timing of doxycycline-azithromycin dual therapy in pediatric mycoplasmal pneumonia. Pakistan journal of pharmaceutical sciences, 38(6), 2264. https://doi.org/10.36721/PJPS.2025.38.6.REG.14009.1
Chicago Style (17th ed.) CitationM, Han. "Comparison of Inflammatory Control and Safety by Timing of Doxycycline-azithromycin Dual Therapy in Pediatric Mycoplasmal Pneumonia." Pakistan Journal of Pharmaceutical Sciences 38, no. 6 (2025): 2264. https://doi.org/10.36721/PJPS.2025.38.6.REG.14009.1.
MLA (9th ed.) CitationM, Han. "Comparison of Inflammatory Control and Safety by Timing of Doxycycline-azithromycin Dual Therapy in Pediatric Mycoplasmal Pneumonia." Pakistan Journal of Pharmaceutical Sciences, vol. 38, no. 6, 2025, p. 2264, https://doi.org/10.36721/PJPS.2025.38.6.REG.14009.1.